POINT ROBERTS, Wash., April 21 2011 - www.InvestorIdeas.com, a leader in sector stock including tech stocks, issues a cloud computing stock sector snapshot for morning trading following a recent run in several of the stocks in the sector. Rackspace Hosting (NYSE: RAX), a s pecialist in hosting and cloud computing industry, hit a 52 week- high. The sector leader was VMware Inc. (NYSE: VMW ), closing at $97.90, +$11.93, +13.88% on strong quarterly news. The Company reported year-over-year revenue growth of 33% to $844 Million.

Sector Snapshot

• Elephant Talk Communications Inc. (OTCBB: ETAK) trading at$2.69, down 0.01 (0.37%)
• GBS Enterprises, Inc. (OTCBB: GBSX) trading at $4.25
• Juniper Networks, Inc. (NYSE: JNPR ) trading up at $39.47, up 0.21 (0.53%) 10:12AM EDT
• Rackspace Hosting, Inc (NYSE: RAX) trading at$ 44.26, up 0.34 (0.77%)
• Salesforce.com Inc (NYSE: CRM ) trading at $139.25, down 2.83 (1.99%) 10:15AM EDT, trading as high as $141.98 in earlier trading
• VMware Inc. (NYSE: VMW ) trading at $95.69, down 2.21 (2.26%) 10:16AM EDT

Research Cloud computing stocks
http://www.investorideas.com/TSS/Cloud_Computing_Stocks.asp
Market Snapshot:

• Dow 12,459.07 +5.53 +0.04%
• Nasdaq 2,810.35 +7.84 +0.28%
• S&P 500 1,333.79 +3.43 +0.26%
• 10 Yr Bond(%) 3.38% -0.02
• Oil 111.26 -0.19 -0.17%
• Gold 1,501.70 +3.40 +0.23

Recent News:
VMware Reports First Quarter 2011 Results

• Year-over-Year Revenue Growth of 33% to $844 Million
• EPS Growth of 53% to $0.29; Non-GAAP EPS Growth of 50% to $0.48
• Operating Margin of 18.2%; Non-GAAP Operating Margin of 29.9%
• Trailing Twelve Months Operating Cash Flows Growth of 20% to $1.3 Billion; Free Cash Flows Growth of 39% to $1.3 Billion

PALO ALTO , Calif. , April 19, 2011

• Revenues for the first quarter were $844 million, an increase of 33% from the first quarter of 2010.
• Operating income for the first quarter was $154 million, an increase of 50% from the first quarter of 2010. Non-GAAP operating income for the first quarter was $252 million, an increase of 44% from the first quarter of 2010.
• Net income for the first quarter was $126 million, or $0.29 per diluted share, compared to $78 million, or $0.19 per diluted share, for the first quarter of 2010. Non-GAAP net income for the quarter was $204 million, or $0.48 per diluted share, compared to $133 million, or $0.32 per diluted share, for the first quarter of 2010.
• Operating cash flows for the first quarter were $478 million, an increase of 35% from the first quarter of 2010. Free cash flows for the quarter were $473 million, an increase of 45% from the first quarter of 2010.
• Trailing twelve months operating cash flows were $1.3 billion, an increase of 20%. Trailing twelve months free cash flows were $1.3 billion, an increase of 39%.
• Cash, cash equivalents and short-term investments were $3.7 billion and unearned revenue was $2.0 billion as of March 31, 2011.

U.S. revenues for the first quarter of 2011 grew 26% to $400 million from the first quarter of 2010. International revenues grew 40% to $444 million from the first quarter of 2010.
More: http://www.vmware.com/company/news/releases/vmw-earnings-q111.html
Elephant Talk and Its ValidSoft Subsidiary Featured in Josh Levine's MicroCap Investor Newsletter- Companies Positioned to Profit From "Securing the Mobile Cloud"
SCHIPHOL, THE NETHERLANDS--- Elephant Talk Communications Inc. (OTC.BB: ETAK - News) (http://www.elephanttalk.com) has announced that the company and its wholly-owned subsidiary, ValidSoft Limited, (www.validsoft.com) were featured recently by Josh Levine in his MicroCap Investor newsletter. The report is available at: http://levinesmicrocapinvestor.com/news/2011/04-14-11.aspx
Visit the Cloud computing stocks directory at Investorideas.com
http://www.investorideas.com/TSS/Cloud_Computing_Stocks.asp
Cloud Computing Stock Snapshot:
GBS Enterprises, Inc. (OTCBB:GBSX) is the parent company of Group Business Software (GBS) which provides a portfolio of Cloud Computing software technologies and Application Services to address the needs of private enterprises, Data Center providers, ISV's, OEM's as well as government organizations. GBS caters primarily to mid-market and enterprise B2B size organizations. GBS has over 3,500 customers in thirty-eight countries spanning four continents, representing more than 5,000,000 active users of its product s.
Visit the GBSX company profile on Investorideas.com  
Request news and info on GBSX
Company Contact:
Gary MacDonald
EVP and Chief Corporate Development Officer
GBS Enterprises, Incorporated
+1.917.477.9509
gmacdonald@gbsx.us
Sign up for the free investor news letter and get stock alerts in leading sectors!
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising .
Disclosure: GBS Enterprises, Inc. (OTCBB: GBSX) is a paid showcase tech stock, cloud computing stock on Investorideas.com (April 2011 - 1500 per month by third party)
Disclosure: Investorideas.com is a partner of Josh Levines Microcap. Investorideas.com is not long and is not compensated by ETAK.
www.InvestorIdeas.com/About/Disclaimer.asp
www.Investorideas.com
Dawn Van Zant: 800-665-0411 - dvanzant@investorideas.com
Source - Investorideas.com

Biotech/Pharma Investor Spotlight; Profile for BioSante Pharmaceuticals (NASDAQ: BPAX) and its Lead Products, LibiGel® and Bio-T-Gel™

Point Roberts, WA - April 21, 2011 (Investorideas.com Newswire) Investorideas.com, a leader in sector stock research including biotech and pharma stocks, profiles BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) and its lead products, LibiGel® (testosterone gel) and Bio-T-Gel.
Hi-lights are featured within the research report, updated product brochure, recent news and a recent Q&A interview.
Recent Equity Research:
"Our $5 price target is derived by applying a 5x multiple to our base case projection for LibiGel sales of $422MM in 2016, discounted by 30% per year." JMP Securities
Read the full report:
http://www.investorideas.com/CO/BPAX/news/Initiating-Coverage-031611.pdf
Recent News for LibiGel Product:
Biotech/Pharma Stock News; BioSante Pharmaceuticals (NASDAQ: BPAX) Completes Enrollment in Both Pivotal LibiGel® Phase III Efficacy Trials
LINCOLNSHIRE , Ill. - March 30, 2011 (Investorideas.com newswire) - BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) today announced that enrollment of subjects in the second of two pivotal Phase III LibiGel (testosterone gel) safety and efficacy trials has been completed. Enrollment in the first LibiGel efficacy trial was completed in February. The efficacy trials are being conducted under an FDA-approved special protocol assessment (SPA) agreement. LibiGel is in development for the treatment of female sexual dysfunction (FSD), specifically, hypoactive sexual desire disorder (HSDD) in menopausal women, for which there is no FDA-approved product.
"This is an important achievement for BioSante and a key step toward completing the LibiGel Phase III clinical development program," said Joanne Zborowski, BioSante's vice president of clinical development. "There are more than 1,000 subjects in the efficacy trials and we anticipate announcing top-line efficacy data this fall. In addition, we have over 3,000 subjects enrolled in our LibiGel Phase III safety study," she added.
Read Full News at: http://www.investorideas.com/CO/BPAX/news/2011/03301.asp
Highlights from the LibiGel Brochure:
Read the Full Brochure at: http://www.biosantepharma.com/libigel/LibiGel-Brochure.pdf
Recent News for Bio-T-Gel: Bio-T-Gel NDA pending with PDUFA date of November 14, 2011. NDA filed by Teva
On April 13, 2011, BioSante announced that a New Drug Application (NDA) has been accepted for filing by the U.S. Food and Drug Administration (FDA) following submission in January 2011 by a subsidiary of Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA). The FDA has assigned a PDUFA date of November 14, 2011. The PDUFA date is the target date for the FDA to complete its review of the NDA.
Bio-T-Gel is a testosterone gel for the treatment of male hypogonadism or low testosterone levels. Bio-T-Gel was developed initially by BioSante, and then it was licensed to Teva for late stage clinical development. Teva is responsible for all Bio-T-Gel regulatory and marketing activities. BioSante will receive certain milestone payments and royalties upon commercialization. The current U.S. market for male testosterone products is over $1.2 billion .
LibiGel R & D Event
On April 7, 2011, BioSante hosted a review of female sexual dysfunction (FSD) and the safety of testosterone in women by independent experts, as well as an update of the LibiGel (testosterone gel) development program, for institutional investors and analysts in New York City. The full presentations and slides presented at the LibiGel R & D Event are available on BioSante’s website at www.biosantepharma.com
Interview
Full interview with Mr. Simes can be read here: http://www.investorideas.com/CO/BPAX/news/2011/03281.asp
About BioSante Pharmaceuticals, Inc.
BioSante (NASDAQ: BPAX) is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSante’s lead products include LibiGel ® (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD) which is in Phase III clinical development under a U.S. Food and Drug Administration (FDA) Special Protocol Assessment. BioSante’s first FDA-approved product is Elestrin™ (estradiol gel) indicated for the treatment of hot flashes associated with menopause, marketed in the U.S. by Azur Pharma, BioSante’s licensee. BioSante also is developing a portfolio of cancer vaccines, four of which have been granted Orphan Drug designation, and are currently in several Phase II clinical trials. Other products are Bio-T-Gel™, a testosterone gel for male hypogonadism, for which an NDA is pending with a PDUFA date of November 14, 2011, licensed to Teva Pharmaceuticals, and an oral contraceptive in Phase II clinical development using BioSante patented technology. Additional information is available online at: www.biosantepharma.com.
This news release may contain forward-looking statements under the Private Securities Litigation Reform Act of 1995. Such statements include statements about BioSante’s plans, objectives, expectations and intentions with respect to future operations and products, future market acceptance, size and potential of LibiGel and other statements identified by words such as "will,” "potential,” "could,” "would,” "can,” "believe,” "intends,” "continue,” "plans,” "expects,” "anticipates,” "estimates,” "may,” other words of similar meaning or the use of future dates. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Uncertainties and risks may cause BioSante’s actual results to be materially different than those expressed in or implied by BioSante’s forward-looking statements. For BioSante, particular uncertainties and risks include, among others, the difficulty of developing pharmaceutical products, obtaining regulatory and other approvals and achieving market acceptance; the marketing success of BioSante’s licensees or sublicensees; the success of clinical testing; and BioSante’s need for and ability to obtain additional financing. More detailed information on these and additional factors that could affect BioSante’s actual results are described in BioSante’s filings with the Securities and Exchange Commission, including its most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q. All forward-looking statements in this presentation speak only as of the date of this presentation. BioSante undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
Contact BioSante:
For Investors:
The Trout Group LLC
> Tricia Swanson
(646) 378-2953
tswanson@troutgroup.com
or
For Media:
McKinney/Chicago
Alan Zachary
(312) 944-6784 ext. 316
azachary@mckinneychicago.com
The full BPAX company profile is available at Investorideas.com
http://www.investorideas.com/CO/BPAX/
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
About InvestorIdeas.com :
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Sign up for the free investor news letter and get stock alerts in leading sectors! http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer: The following news/content is paid for as part of the BPAX showcase program (one thousand per month) Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp 
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp 
Source: Investorideas.com, BioSante, Investorideas.com
Contact Investorideas.com 800 665 0411 cvanzant@investorideas.com

Security Stocks; UPSG (TSX-V: UZZ) MOVES INTO EASTERN CANADA

EDMONTON - April 20, 2011 (InvestorIdeas.com Newswire) - F.V.Ramsoondar, Chief Executive Officer of United Protection Security Group Inc. (UPSG or the Company), (TSX-V:UZZ) announces the appointment of Don Dassanayake as Senior Vice President of Operations and Business Development for Eastern Canada.

Mr. Ramsoondar further states: "Don's appointment is the first step in a national growth strategy that will be deployed in 2011 and beyond. Our objective is to grow the Company into one of the largest national security service providers in Canada over the next five years."
Don was the Chief Financial Officer of the Canadian division of the world's largest security company. He was also a senior member of the executive management and acquisition teams and contributed to the company growing its Canadian operations from $23 million to $200 million in annual revenues. During his tenure he was involved with closing several successful acquisitions.
Don Dassanayake joins UPSG with over 20 years experience in the security industry. He is a member of the Chartered Institute of Management Accountants and past member of the Institute of Data Processing Management in the United Kingdom.
Don's mandate is to build UPSG's Eastern Canada operations through acquisitions and future organic growth.
Stock Awareness Activities
To find out more about United Protection Security Group Inc. (TSX-V:UZZ), visit our website at www.unitedprotection.com. To join the 'request for information', go to the web page www.unitedprotection.com and click the tab 'request information' and follow the prompts. You may also email Investor Relations at: iruzz@unitedprotection.com.
Statements in this press release other than purely historical information, including statements relating to the Company's future plans and objectives or expected results, are forward-looking statements. Forward-looking statements are based on numerous assumptions and are subject to all of the risks and uncertainties inherent in the Company's business, including risks related to business development and retention, and risks related to the current economic and credit conditions. As a result, actual results may vary materially from those described in the forward-looking statements.
The TSX Venture Exchange has neither approved nor disapproved the information contained herein.
Disclosure: UZZ is a paid advertising client on Investorideas.com and our defense portals.

Visit the UZZ showcase profile at Investorideas.com
Request News and Info on UZZ

Published at the Investor Ideas Newswire

Online Mining Investor Conference adds Mining Stock Running Fox (OTC.PK: RFXRF) (TSX-V: RUN) to Growing List of Presenters

April 20, 2011 - www.Investorideas.com and www.SmallCapVoice.com add mining company Running Fox (OTC.PK: RFXRF) (TSX-V: RUN) to the list of presenters at this year’s online investor conference. The online event, Follow the Money in Mining and Metals, will be held May 25 th and 26. Industry Speakers include Eric Coffin from Hard Rock Analyst, Peter Grandich, Lawrence Roulston and Stephen Whiteside of TheUpTrend.com.

The presentations will be an audio format with PowerPoint, averaging 10-15 minutes in length.The online conference will feature leading industry experts speaking on the future of the mining sector, along with management of well- followed mining stocks.

The event will be pre-recorded and go live May 25 th starting at 9:00 a.m. EST. It will be archived after the event has closed and made available for investors with login.

The online conference is free to investors with login registration. Investors will have the opportunity to hear some of the best in the industry provide insight on the future of mining stocks.

Investor registration:

Learn More about the Conference

http://www.investorideas.com/MSS/Conference.asp

Investor Sign-Up

http://www.smallcapvoice.com/ii_scv/investor-signup.html

Public Company Sign-Up

http://www.smallcapvoice.com/ii_scv/company-signup.html

Mining Stocks:

Running Fox (OTC.PK: RFXRF) (TSX-V: RUN)

Running Fox (TSX-V:RUN) (US OTC:RFXRF) (FRANKFURT:C8Q) is a Canadian growth-oriented resource company with mineral projects including US uranium and Canadian gold properties, oil and gas assets, and oilfield service operations.

www.foxgold.ca

Speakers:

Peter Grandich

Grandich is the founder of Grandich.com and Grandich Publications, LLC, and is editor of The Grandich Letter which was first published in 1984. On his internationally-followed blog, he comments daily about the world's economies and financial markets and posts his views on social and political topics. He also blogs about a variety of timely subjects of general interest and interweaves his unique brand of humor and every-man "Grandichism" expressions with his experience gained from more than 25 years in and around Wall Street. The result is an insightful and intuitive look at business, finances and the world, set in a vernacular that just about anyone can understand. In his first year, Grandich's wildly-popular blog had more than one million views. Grandich also provides a variety of services to publicly-held corporations on a compensation basis.

Lawrence Roulston

Roulston, editor, is a geologist, with engineering and business training, and more than 20 years of hands-on experience in the resource industry. Lawrence is ideally suited to publish Resource Opportunities. After completing his studies at the University of British Columbia in 1975, Mr. Roulston worked as an analyst for Cominco Ltd. and for a mid-sized Calgary oil group for several years. In 1984 he became the CFO for a group of mineral exploration companies. He was also vice-president in an investment management firm focused on the resource industry. From 1994 to 1997, he was CEO and director of a mineral exploration company.

http://www.resourceopportunities.com

Stephen Whiteside

Stephen Whiteside is the CEO of Whiteside Analytics, and founder of www.TheUpTrend.com.

Stephen started trading commodities in 1984 and became heavily involved in technical analysis in 1987. In 1999, Stephen started sharing his proprietary charts online and attracted an online following. As his online following grew, Stephen started his online charting service TheUpTrend.com in 2001. Currently, TheUpTremd.com has clients in 43 countries and provides daily analysis on over 2,000 of the most actively traded stocks, indexes, ETF's and commodities.

Eric Coffin

Hard Rock Analyst

http://www.hraadvisory.com/

Eric is the "financial analysis" side of the Hard Rock Analyst team and holds a degree in Corporate and Investment Finance. He has extensive experience in merger and acquisitions and small company financing and promotion. For many years he tracked the financial performance and funding of all exchange listed Canadian mining companies and has helped with the formation of several successful exploration ventures.

Eric has been interviewed on national and local TV and radio in Canada and the US for his opinions on resource trends and is a frequent contributor to several third party publications and a number of resource, gold, metals and market related Internet sites.

He regularly speaks at a number of North American gold and resource conferences. He was one of the first analysts (along with brother David) to point out the disastrous effects of gold hedging and gold loan capital financing (1997) and to predict the start of the current secular bull market in commodities based on the movement of the US Dollar (2001) and the acceleration of growth in Asia and India.

Eric reviews data from hundreds of companies seeking strong management and finance teams in undiscovered companies for HRA's readers. Combined with good share structures and projects that David likes, these companies have the potential to make the HRA list and generate gains for their readers.

About our Mining Portals:

www.Gold-MiningStocks.com and www.MiningSectorStocks.com are research portals within the InvestorIdeas.com content umbrella, featuring industry and stock news, exclusive articles and financial columnists, audio interviews and podcasts, investor conferences, blogs, and a directory of over 1200 mining stocks.

About InvestorIdeas.com: Investor Ideas that Can Change the World

Investor Ideas is a global financial media online destination specialized in sector investing content including mining and energy stocks.

About SmallCapVoice.com, Inc.: Specializing in Covering Small Cap Stocks & Providing Small Cap Investor Relations

Recognized corporate investor relations firm SmallCapVoice.com, Inc. is known for its ability to help emerging growth companies build a following among retail and institutional investors.

Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. www.InvestorIdeas.com/About/Disclaimer.asp

For info on presenting as a public company, speaker or media sponsor contact

Cali Van Zant: 800-665-0411 - cvanzant@investorideas.com

Stuart T. Smith CEO
512-267-2430
ssmith@smallcapvoice.com

Source - Investorideas.com, SmallCapVoice.com

Investorideas.com interviews Businessman / Producer Chad A. Verdi. As he heads to
the Cannes Film Festival to oversee the sale of his three feature films

Visit this company: www.thewpconline.com

April 20, 2011 – www.Investorideas.com, a leader in sector research including music and
entertainment, releases the following Q&A interview with featured up and coming Businessman
/ Producer Chad A. Verdi. Verdi is President and CEO of both Verdi Productions and the
Woodhaven Production Company.

Verdi Productions is in the final stages of post production on its feature film Loosies. The film’s
blockbuster cast includes Peter Facinelli, (Twilight), Jaimie Alexander (Thor), Vicent Gallo
(Bufferlo 66) ,Joe Pantoliano (Matrix) ,William Forsythe .(The Rock) and Christy Carlson Roma
(Infected).

Chad A. Verdi the company's CEO and the films producer reports he also recently signed
American Idol star Paul McDonald. McDonald's music to be used in Verdi's feature film Loosies.

Interview

Q- Investorideas.com
Can you give us some background on Verdi Productions and The Woodhaven Production
Company?

A: Managing Partner and Producer; Chad A. Verdi
VP was founded in 2009 as an independent and fully-funded media production company
based in New York City and RI. We currently have three movies in the pipeline and we are just
finishing our first feature film Loosies. VP will produce the bigger budget films while; The
Woodhaven Production Company will focus on films under 2.5 million dollars. WHP produced
and filmed two features in 2010 and both will be release later this year. Both companies
are positioning themselves to be a serious contender in the film industry.

Q- Investorideas.com
For a new company in the entertainment industry, you have attracted some very impressive
names and talent to your team. Can you give our readers some examples of the range of talent in
your portfolio of movies, Inkubus, Loosies, and Infected?

A: Managing Partner and Producer; Chad A. Verdi
We are extremely excited about the caliber of talent already signed and on board in both VP and
WHP.
We have some great actors that include names like Peter Facinelli ( Twilight / New Moon /
The Scorpion King, Loosies ) Michael Madsen (Reservoir Dogs / Kill Bill: Vol. 1 / Kill Bill: Vol.2
Loosies, Infected), Vicent Gallo ( Buffalo '66 / The Brown Bunny / Tetro/ Loosies ), Joe Pantoliano
( Memento / The Matrix / The Fugitive/ Loosies ), (Jaimie Alexander Thor /Rest Stop / Ground,
Loosies / The Other Side) (William Forsythe, The Rock / Deuce Bigalow: Male Gigolo / Raising
Arizona and Inkubus that are under are VP company. Robert Englund (Freddy vs. Jason / A
Nightmare on Elm Street: The Dream Child / Freddy's Dead: The Final Nightmare, Inkubus),
Christy Carlson Romano (Guiding Light / The Cutting Edge, Mirrows two.: Going for the Gold /
The Even Stevens Movie, Loosies) Jonathan Silverman, (Weekend at Bernie's / 12:01 / Brighton
Beach Memoirs, Inkubus) Joey Fatone (My Big Fat Greek Wedding , Music Group n sync,
Inkubus) and Michelle Ray Smith (Salt and Inkubus).

Q- Investorideas.com
Any other big names involved in your movies?

A: Managing Partner and Producer; Chad A. Verdi

Yes, I just signed a deal with American Idol star Paul McDonald. We will be using many of his
songs in our film Loosies.

Q- Investorideas.com
He is one of my favorites, an artist that I would buy. How did that come about?

A: Managing Partner and Producer; Chad A. Verdi
Peter Facinielli who is very good friends with Niki Reed, who is also in Twilight, told Peter about
Paul's music. Peter then sent his music to me and my wife Michelle, who is the head of music
and talent for both companies. My wife loved his music and gave the ok to sign him. She feels
that Paul's music brings Loosies to life.

Q- Investorideas.com
Can you tell us what stage the companies are at right now and what can audiences expect to see
in the future?

A: Managing Partner and Producer; Chad A. Verdi
Our WHP Company just completed, a horror film entitled "Inkubus", starring Robert Englund. and
Whilliam Forsythe and is in post production on its second horror film Infected, staring Michael
Madsen and Christy Carlson Romano. Both films will be released in 2011.

VP, is in the final stages of post with "Loosies," the tale of a New York pick pocket that
began filming July 15th 2010, that includes stars like Peter Facinelli, Michael Madsen, Vicent
Gallo, Joe Pantoliano and Jaimie Alexander with Michael Corrente directed. Loosies will also be
release in 2011.
.
Q- Investorideas.com
In terms of selling the films, who is representing you?

A: Managing Partner and Producer; Chad A. Verdi
I am in the final stages of signing some of the most respected sales agents in the business and
will release that information at a later date. I am also heading to the Cannes Film Festival in May,
were we willing be selling oversea territories for each film. There has been a lot of attention and
interest in all three films.

Bio for Chad A. Verdi:
Mr. Verdi is an Entrepreneur that at the early age of 18 years old Mr. Verdi acquired his first
business, a RI television listing newspaper called TV Facts that is still in publication today.
By the age of 21 Verdi acquired several other businesses in the food service sector throughout
RI. By age 30, Verdi owned, co-owned or had investments in over a dozen businesses that
ranged from food and toy manufacturing to restaurants and hi-tech developments in the
biotechnology field.
Over the last 13 years, Mr. Verdi has been involved in over 750 million dollars in business
mergers, reverse mergers, start-ups and acquisitions and currently owns, co-owns or has
investments in more than two dozen businesses in diversified industries with more than 500 local
employees and sales of more than $100 million nationwide. He also holds a large real estate
portfolio that includes the 175-year-old former United Methodist Church in East Greenwich where
the constitution of RI was adopted.
View the full company profile for Verdi Corrente Productions (VCP):

http://www.investorideas.com/CO/VCP/

About the Verdi Productions and Woodhaven Production Company:

Both Verdi Productions and The Woodhaven Production Company are fully funded film
production companies, covering all aspects of filmmaking from conception of script through
postproduction.

Contact: Chad A. Verdi, President, The Woodhaven Production Company: 401-884-0655
http://www.thewpconline.com/

Michelle L. Verdi, Head of Music and Talent http://www.imdb.com/name/nm4090091/

Tech Stocks; Elephant Talk (OTCBB:ETAK) and Its ValidSoft Subsidiary Featured in Josh Levine's MicroCap Investor Newsletter Companies Positioned to Profit From "Securing the Mobile Cloud"

SCHIPHOL, THE NETHERLANDS - April 20, 2011 (Investorideas.com Newswire/ Tech Stock News) - Elephant Talk Communications Inc. (OTCBB:ETAK) (http://www.elephanttalk.com) has announced that the company and its wholly-owned subsidiary, ValidSoft Limited, (www.validsoft.com) were featured recently by Josh Levine in his MicroCap Investor newsletter. The report is available at: http://levinesmicrocapinvestor.com/news/2011/04-14-11.aspx

In this latest update on ETAK by Levine, he described Elephant Talk's business model as "Securing the Mobile Cloud." Levine noted that Elephant Talk intends to manage the mobile cloud, or mobile Internet, to provide access to mobile networks for businesses around the global that are non-telecom, non-tech companies but have huge customer databases. Such companies do not want to invest in IT and telecom infrastructure such as antennas and spectrum, but will look to companies such as Elephant Talk to reach their customers and stakeholders, Levine said.
Elephant Talk aims to become "Mobile Central" in the market for mobile cloud services, which includes hundreds of thousands of companies worldwide, Levine added. He also cited experienced management at Elephant Talk by CEO Steven van der Velden and at ValidSoft by CEO Patrick Carroll.
Levine noted that ValidSoft has advanced its business through this arrangement with Visa Europe and other financial institutions for the provision of its fraud-prevention solutions. Levine pointed out that Visa Europe and its 4,000 member banks handle 28 billion transactions a year.
ValidSoft's suite of advanced telecom-based solutions enables banks and other financial institutions to secure all transaction channels, is relatively inexpensive to implement, and is invisible to the customer while maintaining customer privacy, Levine said. ValidSoft has been awarded the European Privacy Seal, he noted.
ValidSoft uses the proximity of a customer's mobile phone to the location where their payment card is being used. If the phone and the card are not in proximity, then it is likely that the transaction is fraudulent, Levine said.
In pilot programs in the U.K. and Australia , ValidSoft's technology has demonstrated that it reduces transaction false positives from an industry average of 90% to virtually none, Levine said.
Levine also pointed out the significance of Elephant Talk and ValidSoft's strategy of positioning their services in the mobile cloud. As mobile phones are adopted by larger populations, especially where many "unbanked" communities rely on such a device for the transfer and receipt of funds, the mobile or smart phone will rapidly become the dominant form of electronic payment. Levine added that ValidSoft's technology also can provide security to a wide range of transactions in the mobile cloud beyond financial services to include health monitoring, among others.
Forward-Looking Statements
Certain statements contained herein constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may include, without limitation, statements with respect to the Company's plans and objectives, projections, expectations and intentions. These forward-looking statements are based on current expectations, estimates and projections about the Company's industry, management's beliefs and certain assumptions made by management. Readers are cautioned that any such forward-looking statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Because such statements involve risks and uncertainties, the actual results and performance of the Company may differ materially from the results expressed or implied by such forward-looking statements. Given these uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. Unless otherwise required by law, the Company also disclaims any obligation to update its view of any such risks or uncertainties or to announce publicly the result of any revisions to the forward-looking statements made here. Additional information concerning certain risks and uncertainties that could cause actual results to differ materially from that projected or suggested is contained in the Company's filings with the Securities and Exchange Commission (SEC), copies of which are available from the SEC or may be obtained upon request from the Company.
About Elephant Talk Communications
Elephant Talk Communications, Inc. (OTC.BB:ETAK) is an international provider of business software and services to the telecommunications and financial services industry. The company enables both mobile carriers and virtual operators to offer a full suite of products, delivery platforms, support services, superior industry expertise and high quality customer service without substantial upfront investments from clients. Elephant Talk provides global telecommunication companies, mobile network operators, banks, supermarkets, consumer product companies, media firms, and other businesses a full suite of products and services that enables them to fully provide telecom services as part of their business offerings. The company offers various dynamic products that include remote health care, credit card fraud prevention, mobile internet ID security, multicountry discounted phone services, loyalty management services, and a whole range of other emerging customized mobile services. For more information visit: www.elephanttalk.com.
About ValidSoft
ValidSoft Limited, headquartered out of Tullamore, Ireland, is a wholly owned subsidiary of Elephant Talk Communications, Inc. (OTC.BB:ETAK - News), and is a market leader in providing solutions to counter electronic fraud relating to cards, the internet, and telephone channels. ValidSoft's solutions are telecommunications based and are at the cutting edge of the market, utilising their access to the most sophisticated global telecommunications networks and expertise. The solutions are used to combat card-present and card-not-present fraud as well as electronic fraud on all channels, including the most advanced fraudulent attacks such as Man-in-the-Browser. The solutions are designed for mass markets, in a highly cost effective and secure manner, yet are easy to use, intuitive and leverage the most ubiquitous devices available. For more information please visit www.validsoft.com. ValidSoft is the first, and only Security Software company in the world to be certified to EuroPriSe standards.
http://www.elephanttalk.com
Josh Levine's MicroCap Investor http://www.levinesmicrocapinvestor.com
Levine's MicroCap Investor delves deep into the world of small stocks to identify big winners, targeting innovative companies on the path of the new and revolutionary.
The strategy for MicroCap Investor is simple: to focus on small, innovative companies representing the best pure plays in the fast-growing waves of change in biotechnology, cleantech, and emerging IT. Learn more about subscribing http://www.levinesmicrocapinvestor.com/subscriptions/order/

Biotech/Biodefense Stock News; ABC News Reports on Aethlon Medical (OTCBB: AEMD)

SAN DIEGO - April 20, 2011 (Investorideas.com newswire) Aethlon Medical, Inc. (OTCBB: AEMD), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, disclosed today that it is the subject of an ABC news story that can be accessed online at: http://www.10news.com/news/27605561/detail.html

About Aethlon Medical
At Aethlon Medical, we create revolutionary devices to address infectious disease and cancer. Our devices are designed to be novel platform solutions that fill therapeutic voids or aid in disease diagnosis and monitoring.
Our Hemopurifier® is the first medical device to selectively target the removal of infectious viruses and immunosuppressive proteins from the entire circulatory system. We recently discovered that our Hemopurifier® captures tumor-secreted exosomes that suppress the immune system of those afflicted with cancer. Prior to this discovery, a therapeutic strategy to directly inhibit or reverse the immunosuppressive destruction caused by exosomes did not exist in cancer care. By eliminating this mechanism, we believe our Hemopurifier® can fill an unmet clinical need and provide the benefit of an immune-based therapy without adding drug toxicity or interaction risks to established and emerging treatment strategies.
Human studies have documented the ability of our Hemopurifier® to safely reduce viral load in both Hepatitis-C virus (HCV) and Human Immunodeficiency Virus (HIV) infected patients without the administration of antiviral drugs. However, our initial clinical and commercialization focus is to establish our Hemopurifier® as an adjunct therapy to enhance the benefit of both infectious disease and cancer treatment regimens. In this regard, we plan to commercialize our Hemopurifier® in India as we advance our clinical strategies in the United States and the European Union. In vitro studies conducted by government and non-government research institutes have also verified that our Hemopurifier® has broad-spectrum capabilities against bioterror and emerging pandemic threats. These studies have confirmed the capture of Dengue Hemorrhagic Virus, Ebola Hemorrhagic Virus, Lassa Hemorrhagic Virus, West Nile Virus, H5N1 Avian Influenza Virus, 2009 H1N1 Influenza Virus, the reconstructed Spanish Flu of 1918 Virus, and Monkeypox Virus, which serves as a model for human Smallpox infection.
As a therapeutic device, the Hemopurifier® provides us with a pipeline into four significant market opportunities:

1. Cancer: A treatment candidate to improve patient responsiveness to established cancer therapies by removing immunosuppressive exosomes from circulation.
2. Hepatitis-C Virus (HCV): As an adjunct therapy to accelerate viral load reduction at the outset of standard of care drug regimens.
3. Human Immunodeficiency Virus (HIV): Provides a potential therapeutic option for HIV-infected individuals to manage disease progression once they become resistant to antiviral drug regimens.
4. Bioterror and Pandemic Threats: Represents the most advanced broad-spectrum strategy to address untreatable bioterror and emerging pandemic threats.

The Hemopurifier® is an expansive multi-patented platform technology whose mechanism of action can be leveraged to provide therapeutic, diagnostic, and biomarker discovery solutions. As a therapeutic, the Hemopurifier® is a single-use disposable cartridge designed for implementation within the established infrastructure of dialysis machines and other blood circulatory pumps already located in hospitals and clinics worldwide.
In design, our Hemopurifier® is a selective filtration device containing affinity agents that tightly bind to high-mannose structures unique to the surface of exosomes produced by cancer and glycoproteins residing on the envelope of viruses. These agents are immobilized around approximately 2800 porous hollow fibers that run the interior length of our device. The resulting design provides us the novel ability to separate both exosome and viral targets away from blood cells so they can then be selectively and permanently removed from the circulatory system. In application, blood circulation is established into the Hemopurifier® via a catheter or other blood access device. Once blood flow has been established, treatment benefit is immediate as the entire circulatory system can pass through the Hemopurifier® in as little as 15 minutes.
Our wholly owned subsidiary, Exosome Sciences, Inc. (ESI) is focused on the development of exosome-targeted products and services that improve cancer diagnosis, provide post-treatment cancer surveillance, and aid in the discovery of biomarkers that allow doctors to optimize patient therapy. Additional information regarding Aethlon Medical and Exosome Sciences can be accessed online at www.aethlonmedical.com.
Certain of the statements herein may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such potential risks and uncertainties include, without limitation, the company's ability to commercialize its Hemopurifier® in India, capability of the Hemopurifier® to reduce viral loads and other disease conditions or to identify or treat disease conditions such as cancer or Hepatitis-C, including the ability to capture exosomes and the impact that potential ability may have on disease conditions, the Company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the ability of the Company to obtain FDA and other regulatory approvals permitting the sale of its products, the Company's ability to manufacture its products either internally or through outside companies and provide its services, the impact of government regulations, patent protection on the Company's proprietary technology, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings.
Contacts:
James A. Joyce
Chairman, CEO
858.459.7800 x301
jj@aethlonmedical.com
John P. Salvador
Director, Communications & Investor Relations
858.459.7800 x307
jps@aethlonmedical.com

AETHLON MEDICAL INC (OTC BB: AEMD) is a Showcase biotech, biodefense and defense stock on Investorideas.com ($one thousand five hundred per month, $five thousand per month in 144 stock)
Effective March 15, 2011

Biotech/Biodefense Stock News; RedChip Research Issues Research Update on Aethlon Medical (OTCBB: AEMD)

ORLANDO, Fla. - April 20, 2011 (Investorideas.com newswire) RedChip Research(TM), a division of RedChip Companies, Inc., today announced it has issued a research update on Aethlon Medical, Inc. (OTCBB: AEMD), a company developing therapeutic filtration devices to address infectious disease and cancer.
To receive a complimentary copy of the RedChip Research Report for AEMD, please visit: http://www.redchip.com/about/aboutmain.asp?rid=357
To learn more about Aethlon Medical, Inc. visit http://www.redchip.com/visibility/investor.asp?symbol=AEMD
About RedChip Companies, Inc.
RedChip Companies is an international, small-cap research and financial public relations firm headquartered in Orlando, Florida; with affiliate offices in Beijing, China; Paris, France; and Seoul, Korea. RedChip delivers concrete, measurable results for its clients through its extensive national and international network of small-cap institutional and retail investors. RedChip has developed the most comprehensive platform of products and services for small-cap companies, including: RedChip Research(TM), Traditional Investor Relations, Digital Investor Relations, Institutional and Retail Conferences, RedChip Small-Cap TV(TM), Shareholder Intelligence, Social Media and Blogging Services, Webcasts, and RedChip Radio(TM). To learn more about RedChip's products and services please visit: http://www.redchip.com/visibility/productsandservices.asp.
"Discovering Tomorrow's Blue Chips Today"(TM)
The RedChip Companies, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=2761

Disclosure
None of the reports issued by RedChip Companies, Inc., constitutes a recommendation for any investor to purchase or sell any particular security nor do they constitute investment advice. RedChip certifies that no part of the analysts' compensation was, is, or will be, directly or indirectly, related to the specific recommendation or views expressed by the analyst in the report. Information contained in the research reports is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. Aethlon Medical, Inc. (AEMD) is a client of RedChip Companies, Inc. and of RedChip Visibility, a division of RedChip Companies. AEMD has agreed to pay RedChip Companies, Inc. a fee of 250,000 shares of Rule 144 stock for twelve (12) months of RedChip Visibility Program and six (6) months of investor awareness services. RedChip Visibility Program services include the preparation of the equity research report(s). The equity research report(s) are prepared for informational purposes only and are paid for by the company portrayed in the report. The equity research report(s) are not a recommendation of a solicitation to purchase or sell any security, nor do they constitute investment advice. Investor awareness services and programs are designed to help companies communicate their investment characteristics. These services may include investor conferences, digital and print distribution of AEMD investor-related materials or services, and radio programming. None of the profiles issued by RedChip Companies, Inc., constitutes a recommendation for any investor to purchase or sell any particular security or that any security is suitable for any investor. Any investor should determine whether a particular security is suitable based on the investor's objectives, other securities holdings, financial situation needs, and tax status. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. RedChip Companies, Inc., employees and affiliates may have positions and affect transactions in the securities or options of the issuers mentioned herein.
Contact:
RedChip Companies Inc.
1-800-REDCHIP (733-2447)
research@redchip.com
http://www.redchip.com

AETHLON MEDICAL INC (OTC BB: AEMD) is a Showcase biotech, biodefense and defense stock on Investorideas.com ($one thousand five hundred per month, $five thousand per month in 144 stock)
Effective March 15, 2011

Gold Hits New $1500 High; Gold Stocks Trading Alert; (NYSE: TCK), (TSX-V: GBB), (TSX-V: RUN), (NYSE:GG)

Point Roberts WA - April 19, 2011 (Investorideas.com Mining Newswire) – www.Investorideas.com, a leader in sector stock research issues a gold stocks trading snapshot as gold reaches $1500 for the first time. Investors following gold stocks can gain insight from leading experts in the sector at the Investorideas.com and Smallcapvoice.com online mining investor conference May 25-26th.

Gold Stocks Snapshot

• Barrick Gold Corporation (NYSE: ABX ) trading up at $54.23, up 0.76 (1.42%) 2:22PM EDT
• Gold Bullion Development Corporation (TSX-V: GBB).trading at $0.4850, on over 300,000 shares in Volume
• Goldcorp Inc (NYSE: GG ) trading up at $54.63, up 0.91 (1.69%) 2:19PM EDT
• Kinross Gold Corporation (NYSE: KGC ) trading at 15.17, down 0.05 (0.33%) 2:18PM EDT
• Running Fox Resource Corp. (TSX-V: RUN)trading at $0.28, up 0.03, (9.80%)
• Teck Resources Limited (NYSE: TCK) trading at $054.18, up 3.50 (6.91%) on over 3.5 Million shares in volume

Market Summary for Commodities (at time of release)

• Oil 108.15 +1.03 +0.96%
• Gold 1,494.00 +1.70 +0.11%

The online conference is free to investors with login registration. Investors will have the opportunity to hear some of the best in the industry provide insight on the future of mining stocks.
Investor registration:
Learn More about the Conference
http://www.investorideas.com/MSS/Conference.asp
Investor Sign-Up
http://www.smallcapvoice.com/ii_scv/investor-signup.html
Public Company Sign-Up
http://www.smallcapvoice.com/ii_scv/company-signup.html
Recent Gold Stocks News;
Teck Resources Limited (NYSE: TCK)
Teck Reports Unaudited First Quarter Results for 2011
VANCOUVER , BRITISH COLUMBIA-- - Teck Resources Limited (TSX: TCK.A) reported earnings attributable to our shareholders of $461 million, or $0.78 per share. Adjusted quarterly profit was $450 million, or $0.76 per share, more than double the $198 million reported in the first quarter of 2010.
"Our adjusted earnings of $0.76 per share for the first quarter were more than double the $0.34 per share in the first quarter last year. The increase was due mainly to significant increases in the prices of coal and copper, notwithstanding lower sales volumes of coal. The quarter did present its challenges with an unusual number of operating issues affecting our production in both copper and coal and adverse weather conditions affecting our rail and port services," said Don Lindsay, President and CEO.
Full News at: http://finance.yahoo.com/news/Teck-Reports-Unaudited-First-iw-979083910.html?x=0&.v=1
Recent Gold Stocks News; Running Fox Resource Corp. (TSX-V: RUN)
TSX Gold Stock News; Running Fox (TSX-V: RUN) Reports it Owns 100% or the Brett Gold and Silver Project
Visit this company: www.foxgold.ca
"VANCOUVER, BRITISH COLUMBIA - April 6, 2011 (Investorideas.com Mining stocks newswire) - Gold Stock News - Running Fox Resources, (TSX VENTURE: RUN; PINK SHEETS: RFXRF; FRANKFURT: C8Q) reports the following news and update;
Steven Schurman, P. Geol (US), CEO, Director, reports: Running Fox Resources, (TSX VENTURE: RUN; PINK SHEETS: RFXRF; FRANKFURT: C8Q) is pleased to report that it has completed the acquisition of the remaining 50% of the its high grade Brett Gold Project.
Full Article: http://www.investorideas.com/news/2011/mining/04062.asp
Recent Gold Stocks News; Gold Bullion Development Corporation (TSX-V: GBB)
Gold Stocks; Gold Bullion (TSX-V: GBB) Develops Plans to Spin Off Its Castle Silver Mine
"Vancouver, British Columbia - April 12, 2011 (Investorideas.com Mining stocks Newswire) - Gold Bullion Development Corp. (CDNX:GBB.V) (Other OTC:GBBFF.PK) (the "Company" or "Gold Bullion") announces its intention to spin off its silver mine, the Castle (Milner) Property in the Gowganda mining district of Ontario, to Gold Bullion shareholders. The Company expects that the proposed spin-off will be in the form of shares of a newly-incorporated, public company called "Castle Silver Mines Inc."
Full Article: http://www.investorideas.com/CO/GBB/news/2011/04121.asp
Published at Investorideas.com and www.Gold-MiningStocks.comand www.MiningSectorStocks.com, portals within the InvestorIdeas.com® content umbrella, feature industry and stock news, exclusive articles and financial columnists, audio interviews and podcasts, investor conferences, blogs, and a directory of stocks in the sector. Industry participants are invited to submit news, articles and research.
Mining Stocks Directory : Research mining stocks and gold stocks:
Directory Features Gold Stocks, Silver Stocks, Uranium Stocks, Copper Stocks, Zinc Stocks and Precious Metals TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading Stock Exchanges -Public companies please contact us with updates, corrections and additions.
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/membership/
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including energy and mining stocks, in addition to global markets including China, India, the Middle East and Australia. Investorideas.com is known for its comprehensive stock directories in each sector and sector specific newswires.
Sign up for the free investor news letter and get stock alerts in leading sectors! http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer/ Disclosure: The following news is paid for and /or published as information only for our readers. Running Fox Resource Corp. (TSX.V: RUN) for three days or press release services (seven hundred) and Gold Bullion (TSX-V: GBB) (five hundred). Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of principal .This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
For Additional Information about Investorideas.com energy portals: 800-665-0411 or cvanzant@investorideas.com